Core Laboratories Statistics Share Statistics Core Laboratories has 46.89M
shares outstanding. The number of shares has increased by -0.06%
in one year.
Shares Outstanding 46.89M Shares Change (YoY) -0.06% Shares Change (QoQ) 0.12% Owned by Institutions (%) 99.99% Shares Floating 46.38M Failed to Deliver (FTD) Shares 10 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 7.7M, so 16.42% of the outstanding
shares have been sold short.
Short Interest 7.7M Short % of Shares Out 16.42% Short % of Float 43.85% Short Ratio (days to cover) 17.28
Valuation Ratios The PE ratio is 25.85 and the forward
PE ratio is 12.75.
Core Laboratories's PEG ratio is
-1.7.
PE Ratio 25.85 Forward PE 12.75 PS Ratio 1.55 Forward PS 0.9 PB Ratio 3.22 P/FCF Ratio 18.72 PEG Ratio -1.7
Financial Ratio History Enterprise Valuation Core Laboratories has an Enterprise Value (EV) of 972.77M.
EV / Sales 1.86 EV / EBITDA 13.28 EV / EBIT 17.25 EV / FCF 22.43
Financial Position The company has a current ratio of 2.32,
with a Debt / Equity ratio of 0.71.
Current Ratio 2.32 Quick Ratio 1.71 Debt / Equity 0.71 Debt / EBITDA 2.46 Debt / FCF 4.15 Interest Coverage 4.73
Financial Efficiency Return on Equity is 12.46% and Return on Invested Capital is 8.1%.
Return on Equity 12.46% Return on Assets 5.32% Return on Invested Capital 8.1% Revenue Per Employee $154.07K Profits Per Employee $9.24K Employee Count 3,400 Asset Turnover 0.89 Inventory Turnover 7.33
Taxes Income Tax 14.03M Effective Tax Rate 30.39%
Stock Price Statistics The stock price has increased by -51.32% in the
last 52 weeks. The beta is 1.41, so Core Laboratories's
price volatility has been higher than the market average.
Beta 1.41 52-Week Price Change -51.32% 50-Day Moving Average 11.7 200-Day Moving Average 15.18 Relative Strength Index (RSI) 37.25 Average Volume (20 Days) 487,612
Income Statement In the last 12 months, Core Laboratories had revenue of 523.85M
and earned 31.4M
in profits. Earnings per share was 0.67.
Revenue 523.85M Gross Profit 88.37M Operating Income 58.56M Net Income 31.4M EBITDA 73.27M EBIT 58.56M Earnings Per Share (EPS) 0.67
Full Income Statement Balance Sheet The company has 19.16M in cash and 180.14M in
debt, giving a net cash position of -160.99M.
Cash & Cash Equivalents 19.16M Total Debt 180.14M Net Cash -160.99M Retained Earnings 150.28M Total Assets 602.11M Working Capital 132.91M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 56.39M
and capital expenditures -13.03M, giving a free cash flow of 43.36M.
Operating Cash Flow 56.39M Capital Expenditures -13.03M Free Cash Flow 43.36M FCF Per Share 0.92
Full Cash Flow Statement Margins Gross margin is 16.87%, with operating and profit margins of 11.18% and 5.99%.
Gross Margin 16.87% Operating Margin 11.18% Pretax Margin 8.82% Profit Margin 5.99% EBITDA Margin 13.99% EBIT Margin 11.18% FCF Margin 8.28%
Dividends & Yields CLB pays an annual dividend of $0.05,
which amounts to a dividend yield of 0.38%.
Dividend Per Share $0.05 Dividend Yield 0.38% Dividend Growth (YoY) 0% Payout Ratio 8.06% Earnings Yield 3.87% FCF Yield 5.34%
Dividend Details Analyst Forecast The average price target for CLB is $12.5,
which is 28.2% higher than the current price. The consensus rating is "Hold".
Price Target $12.5 Price Target Difference 28.2% Analyst Consensus Hold Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number 9 Graham Upside -7.69%
Stock Splits The last stock split was on Jul 9, 2010. It was a
forward
split with a ratio of 2:1.
Last Split Date Jul 9, 2010 Split Type forward Split Ratio 2:1
Scores Altman Z-Score 2.28 Piotroski F-Score 5
